New Key Statistics Module, Z-Score and F-Score
SZSE:000950 Key Ratios
Market Cap ¥ M | 8,537.23 |
Enterprise Value ¥ M | 23,390.24 |
P/E(ttm) | 14.53 |
PE Ratio without NRI | 8.98 |
Forward PE Ratio | -- |
Price/Book | 0.75 |
Price/Sales | 0.11 |
Price/Free Cash Flow | 27.29 |
Price/Owner Earnings | 36.87 |
Payout Ratio % | 0.11 |
Revenue (TTM) ¥ M | 80,123.00 |
EPS (TTM) ¥ | 0.34 |
Beneish M-Score | -2.32 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 21.00 |
y-y EBITDA Growth Rate % | -25.60 |
EV-to-EBIT | 10.81 |
EV-to-EBITDA | 10.81 |
PEG | 0.43 |
Shares Outstanding M | 1,728.18 |
Net Margin (%) | 0.74 |
Operating Margin % | 2.85 |
Pre-tax Margin (%) | 1.12 |
Quick Ratio | 1.12 |
Current Ratio | 1.32 |
ROA % (ttm) | 0.93 |
ROE % (ttm) | 5.33 |
ROIC % (ttm) | 5.24 |
Dividend Yield % | 1.01 |
Altman Z-Score | 1.85 |
SZSE:000950 Number of Guru Trades
SZSE:000950 Volume of Guru Trades
Gurus Latest Trades with SZSE:000950
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:000950 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CQ Pharmaceutical Holding Co Ltd Insider Transactions
No Available Data